by Truveta Staff | Sep 22, 2023 | Technology
Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4 million (3M adults and 470,000 children) have active epilepsy in the US. These seizures...
by Truveta Staff | Aug 31, 2023 | Technology
Data captured in electronic health records (EHRs) can provide rich clinical insights about patient journeys and medical histories, gaps in care, treatment outcomes and effectiveness, and more. However, much of this information lies hidden within free-text clinical...
by Truveta Staff | Aug 22, 2023 | Technology
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Truveta Staff | Aug 4, 2023 | Technology
Medical devices play a key role in saving lives and improving patient outcomes on a global scale, yet most information about specific device safety and effectiveness is derived from pre-market clinical trials. Understanding medical device effectiveness in the...
by Lisa Gurry, Chief Growth Officer | Jul 31, 2023 | Technology
Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often become caregivers. Yet, with nearly 7,000 rare diseases (identified as of today…), each is...
by Truveta Staff | Jul 28, 2023 | Technology
Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients...
